Biotech pioneer and startup investor John Martin, who built Gilead into a powerhouse player, has died

John C. Martin, who led Gilead to greatness in developing a hugely profitable HIV drug franchise, has died.

His death at the age of 70 was flagged by the company he built, though Gilead didn’t immediately say what the cause of death was.